Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I trial of cabozantinib and gemcitabine in advanced pancreatic cancer.
Zhen DB, Griffith KA, Ruch JM, Camphausen K, Savage JE, Kim EJ, Sahai V, Simeone DM, Zalupski MM. Zhen DB, et al. Among authors: simeone dm. Invest New Drugs. 2016 Dec;34(6):733-739. doi: 10.1007/s10637-016-0376-1. Epub 2016 Jul 21. Invest New Drugs. 2016. PMID: 27439894 Free PMC article. Clinical Trial.
Early detection and biomarkers in pancreatic cancer.
Misek DE, Patwa TH, Lubman DM, Simeone DM. Misek DE, et al. Among authors: simeone dm. J Natl Compr Canc Netw. 2007 Nov;5(10):1034-41. doi: 10.6004/jnccn.2007.0086. J Natl Compr Canc Netw. 2007. PMID: 18053427 Review.
New frontiers in pancreatic cancer research.
Khan GN, di Magliano MP, Simeone DM. Khan GN, et al. Among authors: simeone dm. Surg Oncol Clin N Am. 2010 Apr;19(2):431-51. doi: 10.1016/j.soc.2009.11.010. Surg Oncol Clin N Am. 2010. PMID: 20159524
Advances in pancreatic cancer.
Kim EJ, Simeone DM. Kim EJ, et al. Among authors: simeone dm. Curr Opin Gastroenterol. 2011 Sep;27(5):460-6. doi: 10.1097/MOG.0b013e328349e31f. Curr Opin Gastroenterol. 2011. PMID: 21778878 Review.
c-Met is a marker of pancreatic cancer stem cells and therapeutic target.
Li C, Wu JJ, Hynes M, Dosch J, Sarkar B, Welling TH, Pasca di Magliano M, Simeone DM. Li C, et al. Among authors: simeone dm. Gastroenterology. 2011 Dec;141(6):2218-2227.e5. doi: 10.1053/j.gastro.2011.08.009. Epub 2011 Aug 22. Gastroenterology. 2011. PMID: 21864475
A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer.
Ben-Josef E, Schipper M, Francis IR, Hadley S, Ten-Haken R, Lawrence T, Normolle D, Simeone DM, Sonnenday C, Abrams R, Leslie W, Khan G, Zalupski MM. Ben-Josef E, et al. Among authors: simeone dm. Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1166-71. doi: 10.1016/j.ijrobp.2012.02.051. Epub 2012 Apr 27. Int J Radiat Oncol Biol Phys. 2012. PMID: 22543215 Free PMC article. Clinical Trial.
249 results